Glynn Capital Management’s AbbVie ABBV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.64M	Sell	14,247 -500	-3%	-$92.8K	0.59%	23
2025 Q1	$3.09M	Hold	14,747	–	–	0.81%	26
2024 Q4	$2.62M	Hold	14,747	–	–	0.62%	25
2024 Q3	$2.91M	Sell	14,747 -10,253	-41%	-$2.02M	0.67%	23
2024 Q2	$4.29M	Hold	25,000	–	–	0.87%	23
2024 Q1	$4.55M	Hold	25,000	–	–	0.85%	25
2023 Q4	$3.87M	Hold	25,000	–	–	0.72%	26
2023 Q3	$3.73M	Hold	25,000	–	–	0.81%	27
2023 Q2	$3.37M	Hold	25,000	–	–	0.75%	25
2023 Q1	$3.98M	Hold	25,000	–	–	0.95%	22
2022 Q4	$4.04M	Hold	25,000	–	–	0.98%	24
2022 Q3	$3.36M	Hold	25,000	–	–	0.72%	27
2022 Q2	$3.83M	Hold	25,000	–	–	0.8%	29
2022 Q1	$4.05M	Hold	25,000	–	–	0.55%	30
2021 Q4	$3.39M	Hold	25,000	–	–	0.36%	32
2021 Q3	$2.7M	Hold	25,000	–	–	0.24%	38
2021 Q2	$2.82M	Hold	25,000	–	–	0.26%	29
2021 Q1	$2.71M	Hold	25,000	–	–	0.26%	29
2020 Q4	$2.68M	Hold	25,000	–	–	0.26%	28
2020 Q3	$2.19M	Hold	25,000	–	–	0.23%	33
2020 Q2	$2.45M	Hold	25,000	–	–	0.31%	27
2020 Q1	$1.91M	Hold	25,000	–	–	0.36%	28
2019 Q4	$2.21M	Hold	25,000	–	–	0.39%	25
2019 Q3	$1.89M	Hold	25,000	–	–	0.35%	27
2019 Q2	$1.82M	Buy	+25,000	New	+$1.82M	0.31%	27